NCT00041431

Brief Summary

To determine the effects of estrogen therapy on postmenopausal women with congestive heart failure.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Dec 2001

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2001

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 8, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 9, 2002

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2003

Completed
Last Updated

May 13, 2016

Status Verified

May 1, 2005

First QC Date

July 8, 2002

Last Update Submit

May 12, 2016

Conditions

Interventions

Eligibility Criteria

AgeUp to 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Postmenopausal women with NYHA Class II or Class III congestive heart failure due to idiopathic dilated cardiomyopathy.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

Cardiovascular DiseasesHeart FailureHeart Diseases

Interventions

Hormone Replacement Therapy

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeutics

Study Officials

  • Steven Reis

    University of Pittsburgh

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Sponsor Type
NIH

Study Record Dates

First Submitted

July 8, 2002

First Posted

July 9, 2002

Study Start

December 1, 2001

Study Completion

December 1, 2003

Last Updated

May 13, 2016

Record last verified: 2005-05